NCT06401668

Brief Summary

Produce prescription programs (PRx) are promising interventions for improving health outcomes for patients with both type 2 diabetes (T2D) and food insecurity, but uptake has been suboptimal. There is a critical need for scalable, evidence-based implementation strategies for improving PRx uptake and optimizing the effectiveness and cost-effectiveness of these interventions. This study will co-design and pilot a community health worker (CHW) strategy and test the effectiveness of the strategy compared to PRx participants without a CHW. The overall objective of this study is to test and evaluate a theory-informed, user-centered community health worker (CHW) implementation strategy to improve uptake of a PRx, among Hispanic Medicaid-eligible patients with T2D in Connecticut (CT). CHWs will offer participants personalized support by overcoming barriers and leveraging facilitators to PRx uptake.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 7, 2024

Completed
11 months until next milestone

Study Start

First participant enrolled

April 8, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

12 months

First QC Date

May 1, 2024

Last Update Submit

February 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • PRx redemption

    PRx redemption is defined as produce debit card dollars used/total dollars available will be collected from the produce debit card platform.

    Monthly, beginning 1 month after the study start though the end of the six month study period.

Secondary Outcomes (9)

  • Barriers to PRx uptake

    3 months, 6 months

  • PRx uptake: Initiation

    6 months

  • PRx uptake: Usage

    6 months

  • PRx uptake: Attendance

    6 months

  • Program Satisfaction

    6 months

  • +4 more secondary outcomes

Study Arms (2)

PRx with the CHW strategy

EXPERIMENTAL

Participants in this group will have CHWs to offer participants personalized support by overcoming barriers and leveraging facilitators to PRx uptake.

Behavioral: Community health worker (CHW) strategyBehavioral: PRx Program

PRx without the CHW strategy

ACTIVE COMPARATOR

Participants in this group will participate in the PRx without the use of CHWs

Behavioral: PRx Program

Interventions

CHWs will offer participants personalized support to assist in overcoming barriers and leveraging facilitators to PRx uptake. CHWs are trained lay members of the communities they serve. The CHW strategy is an evidence-based.

PRx with the CHW strategy
PRx ProgramBEHAVIORAL

The PRx Program provides free fruit and vegetables and nutrition education to patients with T2D and food insecurity.

PRx with the CHW strategyPRx without the CHW strategy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be a current primary or specialty care patient at Hartford Hospital
  • Live in Hartford County
  • Identify as Hispanic
  • Have a current diagnosis of Type II Diabetes
  • Be eligible for Medicaid based on household income and size.

You may not qualify if:

  • Does not speak English or Spanish
  • Has a diagnosis of gestational diabetes
  • Individuals who are members of vulnerable populations, such as individuals who are incarcerated and individuals who are not able to consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hartford HealthCare/ St. Vincent Medical Center

Hartford, Connecticut, 06102, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Community Health Workers

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Allied Health PersonnelHealth PersonnelHealth Care Facilities Workforce and Services

Study Officials

  • Rafael Perez-Escamilla, MD

    Yale School of Public Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Eligible participants will include primary and specialty care patients who identify as Hispanic with T2D and low incomes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2024

First Posted

May 7, 2024

Study Start

April 8, 2025

Primary Completion

March 31, 2026

Study Completion

March 31, 2026

Last Updated

February 4, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Data generated within this study will be provided to the American Heart Association in a de-identified form, to be deposited within the Health Care x Food data repository on the Precision Medicine Platform, and subject to the Precision Medicine Platform Terms and Conditions. Data on the Precision Medicine Platform will be collated with data from other studies that are funded by the American Heart Association Health Care x Food initiative, and used by future investigators for analysis. In addition, data will be made available on Clinicaltrials.gov in alignment with agreed-upon Open Science Policies at the American Heart Association, whereby any factual data that is needed for independent verification of research results must be made freely and publicly available in an AHA-approved repository as soon as possible, and no later than the time of an associated publication or the end of the award period (and any no-cost extension), whichever come first.

Locations